Matches in Wikidata for { <http://www.wikidata.org/entity/Q37201787> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- Q37201787 description "article científic" @default.
- Q37201787 description "article scientifique" @default.
- Q37201787 description "articolo scientifico" @default.
- Q37201787 description "artigo científico" @default.
- Q37201787 description "artículu científicu espublizáu en 2016" @default.
- Q37201787 description "bilimsel makale" @default.
- Q37201787 description "scientific article published on September 2016" @default.
- Q37201787 description "vedecký článok" @default.
- Q37201787 description "vetenskaplig artikel" @default.
- Q37201787 description "videnskabelig artikel" @default.
- Q37201787 description "vědecký článek" @default.
- Q37201787 description "wetenschappelijk artikel" @default.
- Q37201787 description "wissenschaftlicher Artikel" @default.
- Q37201787 description "наукова стаття, опублікована у вересні 2016" @default.
- Q37201787 description "научни чланак" @default.
- Q37201787 description "مقالة علمية نشرت في سبتمبر 2016" @default.
- Q37201787 name "Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?" @default.
- Q37201787 name "Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?" @default.
- Q37201787 name "Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?" @default.
- Q37201787 type Item @default.
- Q37201787 label "Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?" @default.
- Q37201787 label "Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?" @default.
- Q37201787 label "Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?" @default.
- Q37201787 prefLabel "Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?" @default.
- Q37201787 prefLabel "Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?" @default.
- Q37201787 prefLabel "Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?" @default.
- Q37201787 P1433 Q37201787-FA5896DD-5E80-4276-A4EA-B05DFF01B964 @default.
- Q37201787 P1476 Q37201787-53B942BD-C03A-4C36-8B71-667317B40D65 @default.
- Q37201787 P2093 Q37201787-0BBBE487-5676-4037-BB3E-4241742683CF @default.
- Q37201787 P2093 Q37201787-3EEB5925-BF7D-41FD-8A41-978B234C8352 @default.
- Q37201787 P2093 Q37201787-90292941-CC92-452D-96ED-0260A38F468F @default.
- Q37201787 P2093 Q37201787-A729AF8A-7347-4B89-A49B-1654D5C0C287 @default.
- Q37201787 P2093 Q37201787-BC8EC12F-EF40-4C74-9D20-E8396826EC94 @default.
- Q37201787 P2860 Q37201787-04FDEA7C-AB83-4717-9E2B-508E1F0F38AB @default.
- Q37201787 P2860 Q37201787-0F4E7865-11F4-4E91-95AD-150F170A6562 @default.
- Q37201787 P2860 Q37201787-1839009C-31EC-4BFC-B179-7B0D4E7C6DE3 @default.
- Q37201787 P2860 Q37201787-2B01A2C9-43CA-437A-84B8-899690F04D75 @default.
- Q37201787 P2860 Q37201787-2D259ED9-EDA1-4041-B69C-E31EE199D45C @default.
- Q37201787 P2860 Q37201787-349DA4B2-6472-4AAC-A8B6-4E29F5A499A9 @default.
- Q37201787 P2860 Q37201787-60E14448-BFF4-4E93-9070-797F170E727D @default.
- Q37201787 P2860 Q37201787-6BAEDDF5-5F48-4DD0-BD82-A557EDC19947 @default.
- Q37201787 P2860 Q37201787-966EF0D3-B317-4ADC-A9B9-3789E270C041 @default.
- Q37201787 P2860 Q37201787-B1024D89-3ED9-4D2F-B60E-C899AF5145BA @default.
- Q37201787 P2860 Q37201787-B2130DE7-DB87-4036-8A46-181645DE3CDD @default.
- Q37201787 P304 Q37201787-04F81B55-61FC-4CBD-9CA2-5615787C5A57 @default.
- Q37201787 P31 Q37201787-679615C5-7D9E-4DBA-8C6F-4774B0572025 @default.
- Q37201787 P356 Q37201787-ED67B92F-B89C-4B05-A06E-D380CAF6740F @default.
- Q37201787 P433 Q37201787-C9BD3FB3-EDA3-4F9F-8CD9-720DB6C7774D @default.
- Q37201787 P478 Q37201787-CB5B1049-7065-4E6F-95CD-E564A3132261 @default.
- Q37201787 P50 Q37201787-46D40006-400A-4AA8-8616-609F8A838904 @default.
- Q37201787 P577 Q37201787-45C57B66-AC5F-4943-8EF2-63046C27E913 @default.
- Q37201787 P698 Q37201787-F324C006-B601-4FB7-964B-47641E4A4380 @default.
- Q37201787 P932 Q37201787-C7F817B1-C1EE-4AF1-9242-B12A960B722B @default.
- Q37201787 P356 OMJ.2016.78 @default.
- Q37201787 P698 27602197 @default.
- Q37201787 P1433 Q3618856 @default.
- Q37201787 P1476 "Is the Ratio of Antibodies Against Oxidized LDL to Oxidized LDL an Indicator of Cardiovascular Risk in Psoriasis?" @default.
- Q37201787 P2093 "Devinder Mohan Thappa" @default.
- Q37201787 P2093 "G Revathy" @default.
- Q37201787 P2093 "Laxmisha Chandrashekar" @default.
- Q37201787 P2093 "Malathi Munisamy" @default.
- Q37201787 P2093 "Sunitha S" @default.
- Q37201787 P2860 Q31857986 @default.
- Q37201787 P2860 Q35649236 @default.
- Q37201787 P2860 Q36581786 @default.
- Q37201787 P2860 Q36789663 @default.
- Q37201787 P2860 Q37037196 @default.
- Q37201787 P2860 Q37594647 @default.
- Q37201787 P2860 Q37938848 @default.
- Q37201787 P2860 Q41437034 @default.
- Q37201787 P2860 Q72235735 @default.
- Q37201787 P2860 Q78099448 @default.
- Q37201787 P2860 Q87503148 @default.
- Q37201787 P304 "390-393" @default.
- Q37201787 P31 Q13442814 @default.
- Q37201787 P356 "10.5001/OMJ.2016.78" @default.
- Q37201787 P433 "5" @default.
- Q37201787 P478 "31" @default.
- Q37201787 P50 Q56754337 @default.
- Q37201787 P577 "2016-09-01T00:00:00Z" @default.
- Q37201787 P698 "27602197" @default.
- Q37201787 P932 "4996963" @default.